MedTrace Logo

Intensive Medical Treatment for Nephropathy Caused by Type 2 Diabetes With Hypertension

NCT00407680 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2007-10-23

No results posted yet for this study

Summary

To observe the effect of intensive medical treatment for type 2 diabetic patients with hypertension: to discover whether or not intensive medical treatment improves proteinuria, and the difference between the clinical meaning of responder and non-responder (criteria: 50% reduced proteinuria continuing 6 months or more during the observation period.)

Conditions

Interventions

DRUG

Intensive therapy Valsartan,Fluvastatin

Sponsors & Collaborators

  • Tokai University

    collaborator OTHER

  • Yokohama City University Medical Center

    collaborator OTHER

  • St. Marianna University School of Medicine

    collaborator OTHER

  • Kitasato University

    lead OTHER

Principal Investigators

  • Keiji Tanaka, MD,PhD · Kitasato University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-31
Completion
2009-03-31

Countries

  • Japan

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00407680 on ClinicalTrials.gov